1
|
Shen J, Lu Z, Wang J, Zhang T, Yang J, Li Y, Liu G, Zhang X. Advances of Nanoparticles for Leukemia Treatment. ACS Biomater Sci Eng 2020; 6:6478-6489. [PMID: 33320613 DOI: 10.1021/acsbiomaterials.0c01040] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Leukemia is a liquid tumor caused by a hematopoietic stem cell malignant clone, which seriously affects the normal function of the hematopoietic system. Conventional drugs have poor therapeutic effects due to their poor specificity and stability. With the development of nanotechnology, nonviral nanoparticles bring hope for the efficient treatment of leukemia. Nanoparticles are easily modified. They can be designed to target lesion sites and control drug release. Thereby, nanoparticles can improve the effects of drugs and reduce side effects. This review mainly focuses on and summarizes the current research progress of nanoparticles to deliver different leukemia therapeutic drugs, as to demonstrate the potential of nanoparticles in leukemia treatment.
Collapse
Affiliation(s)
- Jie Shen
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China.,School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, PR China
| | - Zhiguo Lu
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China.,School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, PR China
| | - Jianze Wang
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China
| | - Tianlu Zhang
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China
| | - Jun Yang
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China
| | - Yan Li
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China
| | - Guiying Liu
- Department of Pediatrics, Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing, 100029, PR China
| | - Xin Zhang
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, PR China
| |
Collapse
|
2
|
Cortese B, D'Amone S, Testini M, Ratano P, Palamà IE. Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy. Cancers (Basel) 2019; 11:E1338. [PMID: 31510037 PMCID: PMC6769784 DOI: 10.3390/cancers11091338] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2019] [Revised: 09/04/2019] [Accepted: 09/05/2019] [Indexed: 01/08/2023] Open
Abstract
Background: A great number of therapeutic limitations, such as chemoresistance, high dosage, and long treatments, are still present in cancer therapy, and are often followed by side effects such as infections, which represent the primary cause of death among patients. Methods: We report pH- and enzymatic-responsive hybrid clustered nanoparticles (HC-NPs), composed of a PCL polymeric core loaded with an anticancer drug, such as Imatinib Mesylate (IM), and coated with biodegradable multilayers embedded with antibacterial and anticancer baby-ship silver NPs, as well as a monoclonal antibody for specific targeting of cancer cells conjugated on the surface. Results: The HC-NPs presented an onion-like structure that serially responded to endogenous stimuli. After internalization into targeted cancer cells, the clustered nanoparticles were able to break up, thanks to intracellular proteases which degraded the biodegradable multilayers and allowed the release of the baby-ship NPs and the IM loaded within the pH-sensible polymer present inside the mothership core. In vitro studies validated the efficiency of HC-NPs in human chronic leukemic cells. This cellular model allowed us to demonstrate specificity and molecular targeting sensitivity, achieved by using a combinatorial approach inside a single nano-platform, instead of free administrations. The combinatory effect of chemotherapic drug and AgNPs in one single nanosystem showed an improved cell death efficacy. In addition, HC-NPs showed a good antibacterial capacity on Gram-negative and Gram-positive bacteria. Conclusions: This study shows an important combinatorial anticancer and antimicrobial effect in vitro.
Collapse
Affiliation(s)
- Barbara Cortese
- Nanotechnology Institute, CNR-NANOTEC, University La Sapienza, P.zle A. Moro, 00185 Rome, Italy.
| | - Stefania D'Amone
- Nanotechnology Institute, CNR-NANOTEC, via Monteroni, 73100 Lecce, Italy.
| | - Mariangela Testini
- Nanotechnology Institute, CNR-NANOTEC, via Monteroni, 73100 Lecce, Italy.
| | - Patrizia Ratano
- Nanotechnology Institute, CNR-NANOTEC, University La Sapienza, P.zle A. Moro, 00185 Rome, Italy.
| | | |
Collapse
|
3
|
Karimi Ghezeli Z, Hekmati M, Veisi H. Synthesis of Imatinib-loaded chitosan-modified magnetic nanoparticles as an anti-cancer agent for pH responsive targeted drug delivery. Appl Organomet Chem 2019. [DOI: 10.1002/aoc.4833] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Zahra Karimi Ghezeli
- Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences; Islamic Azad University; Tehran Iran
| | - Malak Hekmati
- Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences; Islamic Azad University; Tehran Iran
| | - Hojat Veisi
- Department of Chemistry; Payame Noor University; Tehran Iran
| |
Collapse
|
4
|
Palamà IE, Di Maria F, Zangoli M, D'Amone S, Manfredi G, Barsotti J, Lanzani G, Ortolani L, Salatelli E, Gigli G, Barbarella G. Enantiopure polythiophene nanoparticles. Chirality dependence of cellular uptake, intracellular distribution and antimicrobial activity. RSC Adv 2019; 9:23036-23044. [PMID: 35514476 PMCID: PMC9067287 DOI: 10.1039/c9ra04782d] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2019] [Accepted: 07/19/2019] [Indexed: 12/18/2022] Open
Abstract
The use of intrinsic chiral molecules opens the door to bio-imaging specific tools and to the development of target-therapy.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Guglielmo Lanzani
- Politecnico di Milano
- Dept. of Physics
- I-20133 Milano
- Italy
- Center for Nano Science and Technology@Polimi
| | | | - Elisabetta Salatelli
- Dept. of Industrial Chemistry Toso Montanari
- University of Bologna
- 40136 Bologna
- Italy
| | - Giuseppe Gigli
- CNR NANOTEC
- 73100 Lecce
- Italy
- Dept. of Mathematics and Physics Ennio De Giorgi
- University of Salento
| | | |
Collapse
|
5
|
Popov AL, Popova NR, Tarakina NV, Ivanova OS, Ermakov AM, Ivanov VK, Sukhorukov GB. Intracellular Delivery of Antioxidant CeO2 Nanoparticles via Polyelectrolyte Microcapsules. ACS Biomater Sci Eng 2018; 4:2453-2462. [DOI: 10.1021/acsbiomaterials.8b00489] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Anton L. Popov
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Moscow Region, Pushchino 142290, Russia
| | - Nelli R. Popova
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Moscow Region, Pushchino 142290, Russia
| | - Nadezda V. Tarakina
- School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, United Kingdom
| | - Olga S. Ivanova
- Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow 117901, Russia
| | - Artem M. Ermakov
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Moscow Region, Pushchino 142290, Russia
| | - Vladimir K. Ivanov
- Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, Moscow 117901, Russia
- National Research Tomsk State University, Tomsk 634050, Russia
| | - Gleb B. Sukhorukov
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Moscow Region, Pushchino 142290, Russia
- School of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, United Kingdom
| |
Collapse
|
6
|
Cortese B, D'Amone S, Palamà IE. Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy. Pharmaceutics 2018; 10:E52. [PMID: 29670043 PMCID: PMC6027521 DOI: 10.3390/pharmaceutics10020052] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Revised: 04/11/2018] [Accepted: 04/12/2018] [Indexed: 11/16/2022] Open
Abstract
Chronic myeloid leukaemia (CML) is caused by the BCR-ABL oncogene, which encodes the constitutively active BCR-ABL tyrosine kinase. Targeted therapy with tyrosine-kinase inhibitors induces a partial cytogenetic response in most patients. Nanosystems can represent an opportunity for combinatorial therapy with the capacity to simultaneously release different therapeutic agents, checking the pharmacokinetic properties. In this work, we have developed a novel poly-(ε-caprolactone) (PCL) nanosystem for combinatorial therapy in CML, composed of a biodegradable pH sensitive core releasing Nilotinib (Nil) and an enzymatic sensitive outer shell releasing Imatinib Mesylate (IM), resulting in wool-like nanoparticles (NPs). The resulting double loaded wool-like hollow PCL NPs showed a high dual-drug encapsulation efficiency, pH and enzymatic sensitivity and synchronized drug release capability. The combinatorial delivery of IM and Nil exhibited an importantly reduced IC50 value of IM and Nil on leukaemia cells compared to single free drugs administration. In vitro results, showed that combinatorial nanomixures preserved the biological activity of loaded drugs for extensive time windows and led to a constant release of active drug. In addition, the combination of IM and Nil in single PCL NPs have shown a more therapeutic efficiency at a low dose with respect to the single drug nanomixures, confirming that both drugs reached the target cell precisely, maximizing the cytotoxicity while minimizing the chances of cell resistance to drugs.
Collapse
Affiliation(s)
- Barbara Cortese
- Nanotechnology Institute, CNR-Nanotechnology Institute (CNR-NANOTEC), University La Sapienza, P.zle A. Moro, 00185 Roma, Italy.
| | - Stefania D'Amone
- Nanotechnology Institute, CNR-Nanotechnology Institute (CNR-NANOTEC), Monteroni street, 73100 Lecce, Italy.
| | - Ilaria Elena Palamà
- Nanotechnology Institute, CNR-Nanotechnology Institute (CNR-NANOTEC), Monteroni street, 73100 Lecce, Italy.
| |
Collapse
|
7
|
Samir A, Elgamal BM, Gabr H, Sabaawy HE. Nanotechnology applications in hematological malignancies (Review). Oncol Rep 2015; 34:1097-105. [PMID: 26134389 PMCID: PMC4530900 DOI: 10.3892/or.2015.4100] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2014] [Accepted: 02/16/2015] [Indexed: 02/06/2023] Open
Abstract
A major limitation to current cancer therapies is the development of therapy-related side-effects and dose limiting complications. Moreover, a better understanding of the biology of cancer cells and the mechanisms of resistance to therapy is rapidly developing. The translation of advanced knowledge and discoveries achieved at the molecular level must be supported by advanced diagnostic, therapeutic and delivery technologies to translate these discoveries into useful tools that are essential in achieving progress in the war against cancer. Nanotechnology can play an essential role in this aspect providing a transforming technology that can translate the basic and clinical findings into novel diagnostic, therapeutic and preventive tools useful in different types of cancer. Hematological malignancies represent a specific class of cancer, which attracts special attention in the applications of nanotechnology for cancer diagnosis and treatment. The aim of the present review is to elucidate the emerging applications of nanotechnology in cancer management and describe the potentials of nanotechnology in changing the key fundamental aspects of hematological malignancy diagnosis, treatment and follow-up.
Collapse
Affiliation(s)
- Ahmed Samir
- Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
| | - Basma M Elgamal
- Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt
| | - Hala Gabr
- Department of Clinical Pathology, Kasr Al‑Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Hatem E Sabaawy
- Department of Clinical Pathology, Kasr Al‑Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
| |
Collapse
|
8
|
Cortese B, D'Amone S, Gigli G, Palamà IE. Sustained anti-BCR-ABL activity with pH responsive imatinib mesylate loaded PCL nanoparticles in CML cells. MEDCHEMCOMM 2015. [DOI: 10.1039/c4md00348a] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
IM–chitosan complex encapsulated poly(ε-caprolactone) (PCL) nanoparticles are proposed for their potential in enabling more intelligent controlled release and enhancing chemotherapeutic efficiency of IM.
Collapse
Affiliation(s)
- Barbara Cortese
- Institute Nanoscience CNR (NNL, CNR-NANO)
- Lecce
- Italy
- Department of Physics
- University Sapienza
| | | | - Giuseppe Gigli
- Institute Nanoscience CNR (NNL, CNR-NANO)
- Lecce
- Italy
- Dept. Matematica e Fisica ‘Ennio De Giorgi’
- University of Salento
| | | |
Collapse
|
9
|
Palamà IE, Cortese B, D'Amone S, Arcadio V, Gigli G. Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia. Biomater Sci 2015. [DOI: 10.1039/c4bm00289j] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Our couple delivery strategy allowed a sustained downregulation of BCR-ABL for long times in chronic myeloid leukemia, combining two types of polymeric nanoparticles for quick and slow release of IM and DOX.
Collapse
Affiliation(s)
| | - Barbara Cortese
- Institute Nanoscience CNR (NNL
- CNR-NANO) via Arnesano
- Lecce
- Italy
- Dept. of Physics
| | | | | | - Giuseppe Gigli
- Institute Nanoscience CNR (NNL
- CNR-NANO) via Arnesano
- Lecce
- Italy
- Dept. Matematica e Fisica ‘Ennio De Giorgi’
| |
Collapse
|
10
|
Palamà IE, Cortese B, D'Amone S, Gigli G. mRNA delivery using non-viral PCL nanoparticles. Biomater Sci 2015. [DOI: 10.1039/c4bm00242c] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
GFP mRNA-protamine complex encapsulated poly(ε-caprolactone) (PCL) non-viral nanoparticles are proposed for the intracellular delivery of mRNA molecules.
Collapse
Affiliation(s)
- Ilaria E. Palamà
- National Nanotechnology Laboratory
- Institute Nanoscience CNR (NNL
- CNR-NANO)
- Lecce
- Italy
| | - Barbara Cortese
- National Nanotechnology Laboratory
- Institute Nanoscience CNR (NNL
- CNR-NANO)
- Lecce
- Italy
| | - Stefania D'Amone
- National Nanotechnology Laboratory
- Institute Nanoscience CNR (NNL
- CNR-NANO)
- Lecce
- Italy
| | - Giuseppe Gigli
- National Nanotechnology Laboratory
- Institute Nanoscience CNR (NNL
- CNR-NANO)
- Lecce
- Italy
| |
Collapse
|